Correlation of the Myocardial Viability Score with Left Ventricular Ejection Fraction in Patients after Revascularization

Keywords: myocardial scintigraphy, coronary artery disease, revascularization, ejection fraction, myocardial viability, coronary artery bypass grafting, myocardial perfusion


Background. Coronary artery disease (CAD) is one of the main causes of cardiovascular death. The severity of CAD is determined by the left ventricular (LV) dysfunction which is caused by coronary atherosclerosis. The possibility of restoring functional capacity of the heart (ejection fraction (EF)) depends on hibernating volume of the myocardium which is a pitfall in revascularization.

The aim. To assess the correlation between the score of the viable myocardium (VM) and EF with systolic dysfunction and preserved LVEF in patients after coronary artery bypass grafting (CABG).

Material and methods. To implement the set clinical tasks, 62 patients with CAD with preserved systolic function and systolic dysfunction were examined, 35 (56%) patients had heart failure with an EF of 49% (group 2) and less. Twenty-seven (44%) patients had preserved ventricular function of 50% or more (group 1). The mean age of the subjects was 59.6 ± 8.2 years. Five (8.0%) patients denied myocardial infarction. Myocardial scintigraphy was performed on Infinia Hawkeye all purpose imaging system (GE, USA) with integrated CT. The studies were performed in SPECT and SPECT/CT with ECG synchronization (gated SPECT) modes. 99mTc-MIBI with an activity of 555–740 MBq was used. Myocardial scintigraphy was performed in the course of treatment (before CABG and after CABG) according to the One Day Rest protocol. A total of 124 scintigraphic studies were performed.

Results and discussion. Samples of the studied patients “before” and “after” treatment were compared using Wilcoxon matched-pairs test. In group 1 in patients with EF ≥ 50% the score of VM increased after CABG with values from 81.7 CI 95% [78.5; 84.9] to 86.9 CI 95% [84.4; 89.3]. However, the EF itself before and after treatment remained the same or slightly decreased amounting to 54.9 CI 95% [50.8; 59.1] and 52.5 CI 95% [48.6; 56.3]. In group 2 in patients with EF ≤ 49% the amount of VM increased after CABG with values from 59.9 CI 95% [54.9; 64.8] to 65.9 CI 95% [60.2; 71.6] (p = 0.00005). However, the EF itself before and after treatment remained the same, amounting to 28.9 CI 95% [24.8; 32.9] and 31.1 CI 95% [26.8; 35.5] (p = 0.19).

Conclusions. Myocardial viability in both study groups significantly improved, given the high statistical reliability of the results, although LVEF either remained unchanged or changed slightly. Improvement of static parameters (wall perfusion) also confirms positive effect of revascularization with constant dynamic parameters (EF, end-diastolic volume) or statistically insignificant changes thereof. There is no direct correlation between VM and EF.


  1. Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL; STICHES Investigators. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med. 2016;374(16):1511-20.
  2. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, Valkema R, Van Lingen A, Fioretti PM, Visser CA. Relationship between preoperative viability and post-operative improvement in LVEF and heart failure symptoms. J Nucl Med. 2001;42(1):79-86. PMID: 11197985. J Nucl Med. 2001;42(1)
  3. Sciagrà R, Leoncini M, Marcucci G, Dabizzi RP, Pupi A. Technetium-99m sestamibi imaging to predict left ventricular ejection fraction outcome after revascularisation in patients with chronic coronary artery disease and left ventricular dysfunction: comparison between baseline and nitrate-enhanced imaging. Eur J Nucl Med. 2001;28(6):680-7.
  4. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med. 2009;360(10):961-72.
  5. Yan TD, Padang R, Poh C, Cao C, Wilson MK, Bannon PG, Vallely MP. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies. J Thorac Cardiovasc Surg. 2011;141(5):1134-44.
  6. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. EurHeartJ.2020;41(3):407-77.
  7. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726.
  8. Zhang YJ, Iqbal J, Campos CM, Klaveren DV, Bourantas CV, Dawkins KD, Banning AP, Escaned J, de Vries T, Morel MA, Farooq V, Onuma Y, Garcia-Garcia HM, Stone GW, Steyerberg EW, Mohr FW, Serruys PW. Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: Insights from the SYNTAX trial. J Am Coll Cardiol. 2014;64(5):423-32.
  9. Milan E. Myocardial Perfusion [Internet]. In: Castellucci P, Mirzaei S, editors. European Nuclear Medicine Guide. Edition 2020. Available from:!/chapter/209
  10. Peix A, Karell J, Rodríguez L, Cabrera LO, Padrón K, Carrillo R, Mena E, Fernández Y. Gated SPECT Myocardial perfusion imaging, intraventricular synchronism, and cardiac events in heart failure. Clin Nucl Med. 2014;39(6):498-504.
  11. PaulAK,NabiHA.GatedMyocardialPerfusionSPECT:Basic Principles, Technical Aspects, and Clinical Applications. J Nucl Med Technol. 2004;32(4):179-87. PMID: 15576339.
  12. DvorakRA,BrownRK,CorbettJR.InterpretationofSPECT/CTMyocardial Perfusion Images: Common Artifacts and Quality Control Techniques. Radiographics. 2011;31(7):2041-57.
  13. Löffler AI, Kramer CM. Myocardial viability testing to guide coronary revascularization. Interv Cardiol Clin. 2018;7(3):355-65.
  14. Wilcoxon F. Individual Comparisons by Ranking Methods. Biometrics Bulletin. 1945;1(6):80-3
How to Cite
Kundina, V. V., & Babkina, T. M. (2021). Correlation of the Myocardial Viability Score with Left Ventricular Ejection Fraction in Patients after Revascularization. Ukrainian Journal of Cardiovascular Surgery, (4 (45), 36-42.